The BAR (Bin/amphiphysin/Rvs) domain defines an emerging superfamily of proteins implicated in fundamental biological processes by sensing and inducing membrane curvature. We identified a novel autoregulatory function for the BAR domain of two related GAPs' (GTPase-activating proteins) of the GRAF (GTPase regulator associated with focal adhesion kinase) subfamily. We demonstrate that the N-terminal fragment of these GAPs including the BAR domain interacts directly with the GAP domain and inhibits its activity. Analysis of various BAR and GAP domains revealed that the BAR domain-mediated inhibition of these GAPs' function is highly specific. These GAPs, in their autoinhibited state, are able to bind and tubulate liposomes in vitro, and to generate lipid tubules in cells. Taken together, we identified BAR domains as cis-acting inhibitory elements that very likely mask the active sites of the GAP domains and thus prevent down-regulation of Rho proteins. Most remarkably, these BAR proteins represent a dual-site system with separate membrane-tubulation and GAP-inhibitory functions that operate simultaneously.
INTRODUCTION
Members of the Rho family of small guanine-nucleotide-binding proteins are key regulatory molecules that couple changes in the extracellular environment to intracellular signal transduction. They act as intracellular molecular switches by cycling between active (GTP-bound) and inactive (GDP-bound) states [1] . Activation of Rho proteins results in their association with effector molecules that subsequently activate a wide variety of downstream signalling cascades and regulate many important processes in all eukaryotic cells, including motility and endocytic trafficking [2] . The activity of Rho proteins -at a specific time and at a specific site in the cell -is strictly controlled by three classes of regulatory proteins: the GDIs (guanine-nucleotide-dissociation inhibitors), the GEFs (guanine-nucleotide-exchange factors) and the GAPs (GTPase-activating proteins) [1] . These regulators safeguard two distinct cycles: membrane/cytosol partition of the Rho proteins and exchange/hydrolysis of the bound nucleotide.
The GTP-hydrolysis reaction is a fundamental process in living cells and represents an important timer in intracellular processes. The rate of Rho protein-mediated GTP hydrolysis is intrinsically low. Direct interaction with GAPs specific for Rho proteins accelerates the reaction by several orders of magnitude [3] . The RhoGAP functions are critical for the termination of signal transduction [4] . Thus mutations in genes encoding GAPs of the Rho proteins have drastic consequences and underlie several human diseases. OPHN1 (oligophrenin-1) mutations frequently cause X-linked mental retardation that is associated with cerebellar hypoplasia [5] . Another GAP that regulates endocytosis via the CLIC (clathrin-independent carrier)/GEEC (glycosylphosphatidylinositol-enriched endosomal compartment) pathway [6] and has been implicated as a tumour-suppressor gene of acute myelogenous leukaemia and myelodysplastic syndrome is GRAF1 (GTPase-regulator associated with focal adhesion kinase-1) [7] . These RhoGAPs together with PSGAP [PH (pleckstrin homology) and SH3 (Src homology 3) domain-containing Rho-GAP] [8] and GRAF3 (G. Doherty, personal communication) constitute a subfamily of structurally related regulatory proteins. They share an N-terminal BAR (Bin/amphiphysin/Rvs)-like domain, followed by a PH domain and a RhoGAP-related domain ( Figure 1A ). Nadrin (Rich1, ARHGAP17) also has similar architecture but lacks the central PH domain between the BAR and the GAP domain [9] . The BAR domain superfamily of proteins have emerged as important players in membrane-remodelling processes (http://www.bar-superfamily.org). These domains dimerize to sense, and often to induce, membrane curvature [10] [11] [12] . In addition, the BAR domain of arfaptin2/POR1 (partner of Rac1) has been reported to bind differently to ADP-ribosylation factors and Rac1 [13] .
Although the molecular mechanisms of Rho protein regulation by GAPs are well characterized [4] , our understanding of the GAP regulation itself is an open and challenging issue. Recently, we O or PH-GAP O , the BAR-PH-GAP O represents an autoinhibited state of OPHN1, as it exhibited a strongly reduced GAP activity towards Cdc42 · tamraGTP (0.2 μM). The concentration of the GAP proteins was 1 μM. The inset shows the complete time course of the GTPase reaction in the absence (intrinsic; no GAP) or in the presence of BAR-PH-GAP. The observed rate constants (k obs ) obtained by single exponential fitting of the curves were 0.0031 s −1 for the intrinsic reaction (no GAP), 0. have found that the N-terminal region of OPHN1 seems to effect its GAP function and suggested that this part of the protein itself could act as a regulator of GAP activity either by an autoinhibitory mechanism or by binding of a second inhibitory protein [14] . In the present study we investigated a potential role of the N-terminal domains of GRAF1 and OPHN1 on their GAP activities. We describe a novel function for the BAR domains of the GRAF subfamily, which inhibit the activity of the GAP domains and remodel simultaneously lipid membranes.
MATERIALS AND METHODS

Constructs
Human Cdc42 [aa (amino acids) 1-178; GenBank ® accession number NM_001791], Rac1 (aa 1-184; M29870) and RhoA (aa 1-181; L25080) were cloned as described previously [15] . BAR-PH-GAP (aa 1-572), BAR-PH (aa 1-366), PH-GAP (aa 231-572) and GAP (aa 360-572) of OPHN1 (NM_002547), BAR-PH-GAP (aa 1-576), BAR-PH (aa 1-382) and GAP (aa 361- 
Proteins and fluorescent nucleotides
All proteins were produced and prepared as described in [16] . Briefly, the proteins were produced as GST (glutathione transferase) fusion proteins in Escherichia coli BL21 (DE3) or Rosetta (DE3). GSH-Sepharose (Pharmacia) was used as the first purification step. After protease cleavage of the GST tags, the proteins were applied to a gel-filtration column (Superdex 75 or 200, Pharmacia) and a subsequent GSH-Sepharose column as the final step to obtain a purity of at least 95 %. Nucleotidefree GTPases as well as fluorescent nucleotide-bound GTPases were prepared, and concentration and quality were determined as described in [16] . TamraGTP (tetramethylrhodamine-conjugated GTP) was synthesized according to protocols previously established in our laboratory [3, 16] .
Proteolytic cleavage
Purified BAR-PH-GAP was treated with trypsin at a protease/ substrate ratio of 1:4000 at room temperature (25 • C) for up to 48 h. Aliquots from the proteolysis reaction were withdrawn at the indicated time points. The reaction was terminated with 50 μg/ml leupeptin for the trypsin reaction. BAR-PH-GAP cleavage was analysed on SDS/polyacrylamide gels.
Fluorescence measurements
The stopped-flow instrument (Applied Photophysics SX18MV) was routinely utilized for analysis of rapid kinetics, such as GAP-stimulated GTPase reactions (single turnover conditions) as described in [16] . All fluorescence measurements were performed in 30 mM Tris/HCl, pH 7.5, 10 mM KH 2 PO 4 /K 2 HPO 4 , 10 mM MgCl 2 , 50 mM NaCl and 3 mM dithioerythritol at 25
• C.
Isothermal titration microcalorimetry
Titration experiments were carried out at 10
• C with the isothermal titration microcalorimeter VP-ITC (isothermal titration calorimetry) system (Microcal, Northampton, MA, U.S.A.). All protein solutions were prepared in 20 mM Tris/HCl (pH 7.5) by size-exclusion chromatography. The protein concentrations in the calorimetric cell were between 50 and 400 μM. Injections of ligand solution (1-3.5 mM) into the calorimetric cell were carried out at time intervals of 200 s with injection volumes of 8 μl. The injection volume was 8 μl, except for the first step (2 μl). The total number of injections was 60. Spacing time between injections was 4 min. Analysis of the experimental data was carried out with Origin 7.0 software (Microcal). Binding parameters such as number of binding sites (n), the association constant (K a ) and the binding enthalpy ( H • ) were determined as parameters of the fitted experimental binding values.
Liposome co-sedimentation assay
Liposomes were generated from total brain lipids (Folch fraction I) (Sigma-Aldrich) or synthetic lipids [10 % phosphatidylinositol 4,5-bisphosphate, 10 % cholesterol, 40 % phosphatidylethanolamine, 40 % phosphatidylcholine (Avanti Polar Lipids)] and filtered to the specified diameter as previously described [10] . Briefly, the lipid mixtures were dried under a stream of nitrogen and resolved in assay buffer before sonication to generate spherical liposomes. Liposome-binding assays were performed essentially as described in [10] . Briefly, proteins were incubated together with liposomes followed by centrifugation and analysis of the pellet and supernatant on SDS/PAGE.
Transfection and membrane staining
HeLa cells were grown in DMEM (Dulbecco's modified Eagle's medium) media (GIBCO) supplemented with 10 % foetal bovine serum, and transfected for transient protein expression using Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions. For immunofluorescence analysis, HeLa cells were fixed in 3 % (w/v) paraformaldehyde in PBS for 15 min at 22
• C, then washed and blocked in PBS containing 5 % goat serum and 0.1 % saponin before staining with rabbit anti-Myc antibodies (Cell Signaling Technology) in 1 % goat serum, 0.1 % saponin in PBS and secondary Alexa Fluor ® 488-conjugated anti-rabbit antibodies (Invitrogen) using standard protocols. Epifluorescence images were taken using a Zeiss Axioimager Z1 system with AxioVision software.
RESULTS AND DISCUSSION
BAR domain is a cis-acting inhibitory element
In a previous study, we found that full-length OPHN1 showed a much weaker GAP activity compared with the GAP domain alone when overexpressed in cells [14] . To investigate a potential inhibitory mechanism for the catalytic GAP domain, we purified various protein fragments of OPHN1 ( Figure 1A ) and determined their activities in a real-time fluorescence-based GTPhydrolysis assay [3, 16] . The central tool of this assay is a tamraGTP, which is sensitive towards the active state of the Rho proteins and thus can be used to monitor not only the intrinsic but also the GAP-stimulated hydrolysis reactions. In contrast with OPHN1 GAP (denoted GAP O ) and PH-GAP O , which were able to rapidly stimulate the intrinsic GTP-hydrolysis reaction of Cdc42 to the same extent, the GAP activity of BAR-PH-GAP BiochemJ.org/bj/417/bj4170371add.htm). The difference between the K i and K d values is most probably based on different temperature conditions (see the Materials and methods section). In addition, a 1:1 stoichiometry was derived from the ITC curve for this intermolecular interaction. On the basis of the recent dimeric BAR and BAR-PH structures ( [11, 18] and references therein), this result can also be interpreted as a 2:2 complex between BAR-PH and GAP.
In summary, our results showed that OPHN1 exists in an autoinhibited state that is characterized by physical interactions between the BAR-PH and the GAP domains. As a consequence, BAR-PH competitively interferes with complex formation between the GAP domain and cognate Rho protein (Cdc42 · GTP in this case), thereby inhibiting the stimulation of the GTPhydrolysis reaction. This result adds a novel function to the rapidly expanding knowledge of the BAR protein superfamily.
A conserved autoregulatory mechanism for the GRAF subfamily GRAF proteins (GRAF1, 2 and 3) are BAR domain-containing RhoGAPs from the same family as OPHN1 ( Figure 1A ). This is why we have also examined the impact of the corresponding GRAF1 BAR-PH (BAR-PH G ) on the activity of GAP G . Similarly to OPHN1, BAR-PH-GAP G also resided in an autoinhibited state. Its activity in stimulating GTP hydrolysis of Cdc42 was far below that of GAP G alone (Figure 2A ). In addition, GAP G activity was also inhibited in vitro by rapidly mixing BAR-PH G and GAP G in stopped-flow experiments, although higher concentrations were required to achieve an equal inhibition compared with OPHN1 (results not shown Figure S3) . Our data showed that OPHN1 and GRAF1 adopted an autoinhibited state that is provided by an interaction between the BAR-PH and the GAP domains. This novel mechanism is general for proteins in this subfamily.
In contrast with the BAR-PH-containing GRAF subfamily members, stopped-flow experiments with nadrin BAR-GAP (BAR-GAP N ) revealed approximately the same activity as measured for the isolated GAP N domain (Figure 2A ). Even a 50-fold molar excess of the isolated BAR N above the GAP N concentration did not inhibit the GAP-stimulated tamraGTP hydrolysis at all (Figure 2A ). These results led us to the conclusion that BAR N is unable to inactivate GAP N and thus may not be directly involved in the regulation of nadrin GAP activity. It is also important to note that nadrin is not as efficient as OPHN1 and GRAF (Figure 2A There are two possible explanations for this finding. The first and perhaps most probable explanation for the lack of BARmediated regulation of nadrin GAP activity may rely on the nature of the BAR N structure that is different from the classical BAR domains [10, 11, 17] . Nadrin belongs to a subclass of BAR domains that contain an N-terminal amphipathic helix (called N-BAR), which works as functional unit to promote dimerization and membrane curvature generation [18, 19] . It is also necessary to note that nadrin lacks the central PH domain in contrast with GAPs of the GRAF subfamily ( Figure 1A) . Although the PH-GAP O showed no significant change in GAP-stimulated hydrolysis (Figures 1B and 2A) , the possibility that the PH domain might be important for autoinhibition should not be excluded. The isolated BAR domain of OPHN1 or GRAF1 could shed light on this subject, but we have not been successful so far in preparing a stable BAR domain of OPHN1 or GRAF1.
BAR-mediated GAP inhibition is highly specific
After we identified the BAR domain of OPHN1 and GRAF1 as an autoinhibitory element that potently suppresses the GAP activity of these regulators, we next examined whether such an inhibitory activity is interchangeable among other BAR domains. To address this question, we determined the k obs values of the GAPstimulated tamraGTP hydrolysis reaction of Cdc42 in the presence of various BAR domains, including OPHN1, GRAF1, nadrin, amphiphysin, arfaptin-2 and endophilin-A1. As shown in Figure 2( Figure 2C ) that, most remarkably, appeared to be a more potent inhibitor than BAR-PH G itself. This result is consistent with higher binding affinity of BAR-PH O for the GAP O domain and indicates that OPHN1 and GRAF1 autoregulation operates through a similar molecular mechanism.
Another issue that we addressed was whether the BARbinding site of the GAP domain is specific among different GAPs for the Rho family. Therefore we measured stimulation of Cdc42-mediated tamraGTP hydrolysis by the catalytic domain of p50GAP, p190GAP and ABR in the absence and in the presence of BAR-PH O . Figure 2(D) shows that the activity of these GAPs is not affected at all and emphasizes that the BAR domain-mediated autoinhibition of OPHN1 is highly specific.
These results also indicate that the BAR-GAP interaction utilizes signatures, which are selective for the GRAF subfamily of GAPs.
Simultaneous dual-site of action of the BAR domain
The next step of the investigation was to examine the impact of lipid membrane on the autoinhibited state of these GAPs. We repeated the real-time fluorescence measurements of the tamraGTP hydrolysis reaction of Cdc42 in the presence of liposomes and lipid membranes of different size. Representative results are shown in Figure 3(A) . It is evident that the activity of the autoinhibited BAR-PH-GAP was not altered at all. This prompted us to address the question of whether the autoinhibited state of OPHN1 influences membrane-binding and -tubulating abilities of the BAR domain, which was reported previously [10] . Using a liposome co-sedimentation assay, we found that the GAP O domain could be co-sedimented with the membranes if BAR-PH O was present, again showing the trans-interaction. The robust binding of BAR-PH O to liposomes both in the absence and presence of GAP O ( Figures 3B and 3C) suggests that the transinteraction between these domains did not inhibit the membranebinding ability of the BAR-PH O . GAP O was also able to co-sediment with BAR-PH G , but to a much lower extent compared with BAR-PH O ( Figure 3C ). This is in agreement with results described above and again indicates that BAR-PH G exhibits a much weaker GAP-inhibitory effect. Similar results were obtained using β2-centaurin BAR-PH as a control. To investigate further whether membrane binding is influenced in the context of autoinhibited protein, we compared the liposome-binding activity of BAR-PH O and BAR-PH-GAP O . As shown in Figure 3 (D) and 3(E), instead of an inhibitory action, the presence of the GAP domain yielded an even higher amount of BAR-PH-GAP O bound to the liposomes compared with that of BAR-PH O . This result shows that the presence of the GAP domain does not perturb membrane binding but may facilitate the interaction of the BAR domain with the lipid membrane. Moreover, BAR-PH-GAP O was also able to generate lipid tubules when incubated together with liposomes ( Figure 3F ) and to localize to membrane tubules when overexpressed in cells ( Figure 3G ). These data show that BAR-PH O domain was unaffected in its membrane-binding and -tubulating activity, regardless of its interaction with the C-terminal GAP domain. The BAR domain represents a dual-site system, which simultaneously interacts with the GAP domain and the lipid vesicles. In addition, interaction between the GAP and BAR domains seems to potentiate the BAR-mediated ability of membrane binding and remodelling.
CONCLUSIONS
BAR domains recently took centre stage in their area because of their function as membrane curvature-sensing and -stabilizing protein modules [11, 17, [19] [20] [21] . Our work has uncovered a novel autoinhibitory function for BAR domain-containing RhoGAPs of the GRAF subfamily. This is a stringent control mechanism to suppress efficiently and locally the GAP activity of GRAF proteins. Similar autoregulatory modes have been implicated for other RhoGAPs, including DLC1 (deleted in liver cancer 1) and p50RhoGAP. Whereas the mechanism of the autoinhibitory domain remained unknown for DLC1 [22] , an N-terminal Sec14/BCH (Bnip2 and Cdc42 GAP homology) domain has been shown to be essential for the regulation of the GAP activity of p50RhoGAP [23] .
The present study has provided the first evidence for dual-site action of a BAR domain that exhibits simultaneously membraneand protein-binding capabilities with the latter being an inhibitory function on GAPs of the GRAF subfamily. One of the most crucial questions of how the BAR domain of GRAF1 or OPHN1 binds to the GAP domain and inhibits its activity ( Figure 4A ) still remains a subject for further research. Biochemical data from the present and other studies along with the structural determination of BAR domain-containing proteins have shown that BAR-like domains form elongated, banana-shaped, α-helical homodimers in an antiparallel orientation [11] . Therefore intramolecular interactions of a monomer or of a parallel dimer and even an intermolecular head-to-tail dimer ( Figure 4B ) can be excluded. The fact that the BAR domain directly inhibits the GAPstimulated GTPase reaction of Rho proteins supports the notion that it may bind to the Rho-binding region of the GAP domain and thus mask its catalytic residues, including the arginine finger [24] . Moreover, it has been reported that BAR dimers bind membranes electrostatically through their positively charged concave surface [10] . But simultaneous interactions of the BAR domain of OPHN1 with the membrane and the GAP domain suggests that the GAP domain may bind to the convex surface of a banana-shaped homodimer of the BAR domain. Accordingly, an intramolecular interaction between the domains of one protein or an intermolecular interaction between the domains across the two proteins or a transmolecular interaction of one GAP domain and two BAR domains are three alternative symmetrical binding modes of how these domains approach one another ( Figure 4C ). The latter model of an autoinhibited state supports the idea of GAP-induced stabilization of the dimerization state of the BAR domain.
The role of the BAR domain, in conjunction with other domains including the PH domain, is to localize the dormant autoinhibited GAP protein to the membrane. As we know now, this is not sufficient to release the GAP domain and induce GAP activity. Thus an obvious next step of the investigation is to understand the release mechanism of the autoinhibited state of these GAPs. Additional interactions are likely to displace the autoinhibiting BAR domain and to release the GAP domain for specific binding to an adjacent Rho protein at the membrane. This will drive the progression of cellular processes in which GAPs of the GRAF subfamily are required, including dendritic spine morphogenesis and axon growth [25] . Identification of functional modules that inhibit the GAP activity, however, was an important first step towards elucidating underlying cellular mechanism of these critical regulators.
Figure S1 Determination of the specificity of OPHN1 GAP domain
The GAP activity was measured in a HPLC assay as described in [1, 2] using 70 μM GTP-bound G-proteins and 7 nM GAP. The GAP activity was measured in a HPLC assay as described in [1, 2] using 70 μM GTP-bound G-proteins and 7 nM GAP. 
